These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 7912603)

  • 21. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow.
    Ericson SG; Colby E; Welch L; Ball ED
    Bone Marrow Transplant; 1992 Feb; 9(2):129-37. PubMed ID: 1373982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.
    Bisset LR; Lung TL; Kaelin M; Ludwig E; Dubs RW
    Eur J Haematol; 2004 Mar; 72(3):203-12. PubMed ID: 14962239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
    Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
    Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T
    Bone Marrow Transplant; 1994 Feb; 13(2):181-5. PubMed ID: 7515741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].
    Kopiński P
    Folia Med Cracov; 1997; 38(3-4):69-115. PubMed ID: 10481384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of clinical outcome between allogeneic peripheral blood stem cell transplantation and bone marrow transplantation].
    Wang M; Han M; Feng S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):427-30. PubMed ID: 11721425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.
    Talmadge JE; Reed E; Ino K; Kessinger A; Kuszynski C; Heimann D; Varney M; Jackson J; Vose JM; Bierman PJ
    Bone Marrow Transplant; 1997 Jan; 19(2):161-72. PubMed ID: 9116614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
    Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Yamaguchi K; Fukuhara S
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):29-36. PubMed ID: 11862469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT).
    Reimer P; Kunzmann V; Wilhelm M; Weissbrich B; Kraemer D; Berghammer H; Weissinger F
    Ann Hematol; 2003 May; 82(5):263-70. PubMed ID: 12739062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis.
    Ginaldi L; De Martinis M; D'Ostilio A; Marini L; Loreto F; Modesti M; Quaglino D
    Am J Hematol; 2001 Jun; 67(2):63-72. PubMed ID: 11343377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lymphocyte subset reconstitution following human allogeneic bone marrow transplantation].
    Aotsuka N; Asai T; Oh H; Yoshida S
    Rinsho Ketsueki; 1991 Aug; 32(8):844-50. PubMed ID: 1834874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
    Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia.
    Mazur B; Szczepański T; Karpe J; Sońta-Jakimczyk D; Bubała H; Torbus M
    Leuk Res; 2006 Jan; 30(1):33-6. PubMed ID: 16039713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children.
    Locatelli F; Maccario R; Comoli P; Bertolini F; Giorgiani G; Montagna D; Bonetti F; De Stefano P; Rondini G; Sirchia G; Severi F
    Bone Marrow Transplant; 1996 Dec; 18(6):1095-101. PubMed ID: 8971378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy.
    Moritz B; Eder J; Meister B; Heitger A
    Med Pediatr Oncol; 2001 Feb; 36(2):283-9. PubMed ID: 11452936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation.
    Kim DH; Won DI; Lee NY; Sohn SK; Suh JS; Lee KB
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):719-28. PubMed ID: 16785061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood leukocyte subsets and cytokine profile after autologous peripheral blood stem cell transplantation.
    Krause SW; Rothe G; Gnad M; Reichle A; Andreesen R
    Ann Hematol; 2003 Oct; 82(10):628-36. PubMed ID: 12961030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
    Kögler G; Nürnberger W; Fischer J; Niehues T; Somville T; Göbel U; Wernet P
    Bone Marrow Transplant; 1999 Aug; 24(4):397-403. PubMed ID: 10467329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.